[{"id":"5b6257bd-0c69-4e5a-b2f0-4a9d01058631","acronym":"","url":"https://clinicaltrials.gov/study/NCT01284192","created_at":"2021-01-18T05:12:39.060Z","updated_at":"2024-07-02T16:37:31.012Z","phase":"Phase 1","brief_title":"Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)","source_id_and_acronym":"NCT01284192","lead_sponsor":"Astellas Pharma Inc","biomarkers":" ALK","pipe":" | ","alterations":" ALK positive","tags":["ALK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ALK positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ASP-3026"],"overall_status":"Completed","enrollment":" Enrollment 46","initiation":"Initiation: 12/01/2010","start_date":" 12/01/2010","primary_txt":" Primary completion: 02/01/2014","primary_completion_date":" 02/01/2014","study_txt":" Completion: 03/01/2016","study_completion_date":" 03/01/2016","last_update_posted":"2016-06-28"}]